F. Hoffmann-La Roche AG provides in-vitro diagnostics and drugs for cancer and transplantation. The Company specializes in medicines for oncology, virology, inflammation, metabolism, CNS, clinical chemistry, immunology, urinalysis, blood screening, genetics, infectious diseases, and microbiology.
In India, the Pharmaceutical business of F. Hoffmann-La Roche AG is focused on Neuropilin as a Biomarker for Bevacizumab, Bevacizumab (Avastin®), Benzopyran and Benzoxepin Compounds of Formulas I and II, Immunoglobulin Aggregate Removal.
F. Hoffmann-La Roche AG filed patent application numbered 3098/CHENP/2012 that is titled “DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS”. This patent application has been granted as Patent Number 290946.
The invention covers PHARMACEUTICALS. This invention pertains to compounds useful for treatment of diseases associated with P2X purinergic receptors, and more particularly to P2X, and/or P2Z(2/3) antagonists unsable for treatment of genitourinary and pain-related diseases, conditions and disorders.
During patent examination, the patent examiner raised objections under Section 3(d) of the Indian Patents Act, wherein the examiner stated that the Claim(s) 1-6 are statutorily non-patentable under the provision of clause ([d) of Section 3 and the claimed compound is a mere discovery of a new form without any enhancement in therapeutic efficacy.
As a response to said objection, the applicant responded by submitting the scientific structural difference and its characteristic reaction with other chemical compounds.
As a response technical and scientific arguments were presented.
Advocate Rahul Dev is a Patent Attorney & International Business Lawyer practicing Technology, Intellectual Property & Corporate Laws. He is reachable at rd (at) patentbusinesslawyer (dot) com & @rdpatentlawyer on Twitter.
Quoted in and contributed to 50+ national & international publications (Bloomberg, FirstPost, SwissInfo, Outlook Money, Yahoo News, Times of India, Economic Times, Business Standard, Quartz, Global Legal Post, International Bar Association, LawAsia, BioSpectrum Asia, Digital News Asia, e27, Leaders Speak, Entrepreneur India, VCCircle, AutoTech).
Regularly invited to speak at international & national platforms (conferences, TV channels, seminars, corporate trainings, government workshops) on technology, patents, business strategy, legal developments, leadership & management.
